Helen Jones

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes

Darren Hodgson, Brian Dougherty, Zhongwu Lai et al. · British Journal of Cancer · 2018 · 232 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Seven-Day Remote Ischemic Preconditioning Improves Local and Systemic Endothelial Function and Microcirculation in Healthy Humans

Helen Jones, Nicola D. Hopkins, Tom G. Bailey et al. · American Journal of Hypertension · 2014 · 150 citations · Full text

Medicine, Cardiology, Physiology +15

Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers

Helen Swaisland, Alison Laight, Lesley E. Stafford et al. · Clinical Pharmacokinetics · 2001 · 119 citations

Medicine, Pharmacokinetics, Pharmacology +6

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

Patricia LoRusso, Shirish M. Gadgeel, Antoinette Wozniak et al. · Investigational New Drugs · 2008 · 71 citations

Medicine, Oncology, Pharmacology +16

Post‐Exercise Blood Pressure Reduction Is Greater Following Intermittent Than Continuous Exercise and Is Influenced Less by Diurnal Variation

Helen Jones, Chloe E. Taylor, Nia C. S. Lewis et al. · Chronobiology International · 2009 · 67 citations

Education, Cardiology, Physiology +15